UNGA 80: Highlights from the Fourth High-Level Meeting on NCDs and Mental Health / Alejandra Mendez, cancer, Elin Jäger, Georgie Kovacs, Gianluca Pettiti,

Stephen V Liu: Join us for the DC Lung Cancer Conference on October 4th / cancer, DC Lung Cancer Conference, DCLung25, Lung cancer, OncoDaily, Oncology,

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More / cancer, OncoDaily, OncoDaily GI, Oncology, Pancreatic Cancer, radiation

Tian Zhang: Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma / cancer, kidney cancers, Lisa Henske, OncoDaily, Oncology, Tian

This week’s expert highlights in immuno-oncology spotlight trial updates, novel combinations, and leading voices shaping the future of cancer immunotherapy.

INLEXZO FDA approval brings new hope for BCG-unresponsive bladder cancer, offering a bladder-sparing, high-response alternative to surgery.

New Lung Cancer Considered Episode in Mandarin - IASLC / cancer, Chunxia Su, IASLC, Lung Cancer Considered, Nan Bi, OncoDaily, Oncology, The International

Ruben Mesa: An Amazing Cancer Biology Department Driving Advances Across Advocate Health / advocate health, Atrium Health, cancer, cancer biology, OncoDaily,

Paolo Tarantino: New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer / cancer, Medscape PBCC25, Mohamed Kahila, OncoDaily, Oncology, Paolo

10 Must-Read Posts in Immuno-Oncology This Week / Alfonso Duenas Gonzalez, Antonio Nuccio, Biagio Ricciuti, cancer, CAR-T therapy advancements, Christina

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC / cancer, LIBRETTO-431,

Can AI cure cancer? Learn how artificial intelligence improves early diagnosis, supports doctors, and helps patients get faster, accurate care.

Zongertinib is a selective TKI designed to target cancers driven by HER2 mutations. Learn more about its side effects, dosage, expectations.

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee / American Society of Clinical Oncology, ASCO, cancer, Headlines, Herbert

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies / cancer, CaspaCIDe, Dual Switch, GoCAR-T, GoDCVaX, GoTCR, Katy

WCLC 2025 Highlights: FLAURA2 trial / Alessio Cortellini, Alfredo Addeo, Amit Kulkarni, Amol Akhade, Ana I. Velázquez Mañana, Antonio Calles, Bartomeu

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center / cancer, Childhood Cancer, OncoDaily, Oncology, Pakistan, pediatric

Jarushka Naidoo: David O Reilly Wins IASLC Adi Gazdar Grant / Beaumont RCSI Cancer Centre, cancer, David O Reilly, IASLC, Jarushka Naidoo, liquid biopsy,

For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies, and more.

HPV (human papillomavirus) is known to cause many types of cancer in adults, including cancers of the mouth and throat, cervix, vulva, vagina, penis, and anus. Learn more.

Cancer Research UK's annual report and accounts for 2024/25 documents some of the progress we’ve made against our objectives we set last year.